(9) Wajchenberg, BL. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr Rev 2000; 21:697-738.
(10) Sharma, A. M. Adipose tissue: a mediator of cardiovascular risk. International Journal of Obesity, 2002, 26, S5 - S7
(11) Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci. 2005 8:585-9
(12) Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S, et al. Endocannabinoid action at hepatic CB1 receptors regulates fatty acid synthesis: role in diet-induced obesity. J Clin Invest. 2005; 115:1298-1305.
(13) Catalano KJ, Bergman RN, Ader M. Increased susceptibility to insulin resistance associated with abdominal obesity in aging rats. Obesity Research. 2005; 13:11-20
(14) Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73:460-8
Si desea más información, contacte con: Contacto para medios: Wendy Gerber, MS&L PR, Tel: +44-20-7878-3259, E-mail: wendy.gerber@mslpr.com; contacto para medios de World Heart Federation: Clare Courtney, Cohn & Wolfe, PR, Tel: +41-22-908-40-72, E-mail: clare_courtney@ch.cohnwolfe.com
